Delta 9 Opens US Based Showroom for Grow Pod and Equipment Sales
The showroom facility will provide potential Grow Pod customers with a stateside option to view working infrastructure in the United States. Delta 9 has now sold over 250 Grow Pods to third party facilities across North America.
“We are continuing to ramp up our marketing efforts for our Grow Pods in the United States market and this new showroom will play an important role in our US strategy, said John Arbuthnot, CEO of Delta 9, “We feel the US market will provide a significant growth opportunity for our B2B and equipment products in the coming years”.
The Company's cultivation methodology is based around a modular, scalable, and stackable production unit called a "Grow Pod", which are based on retrofitted 40-foot shipping containers. The Grow Pods are built to comply with Health Canada or other State or federal regulatory standards for security and Good Production and Good Agricultural Practices and are optimized for large scale cultivation operations.
The showroom facility is co-located with Malach Metal and Machining Inc. (“Malach”). Malach has facilities located in Winnipeg, Canada and Valley City, North Dakota, USA, and is a world-class supplier of fabricated metal products and supply chain solutions to the OEM, transportation, agricultural, heavy construction, and medical / electronics industries. Malach boasts over 135,000 square feet of manufacturing, storage, and office space at its Canadian and US operations and over 120 staff. Malach has acted as a third-party manufacturing partner of Delta 9’s Grow Pods in the Canadian market and has capacity to provide a “Made in USA” solution for US based Delta 9 Grow Pod customers.
The Grow Pods provide a number of benefits versus traditional open warehouse or green house cultivation operations, namely;
- The Grow Pods provide a high level of control over the growing environment for variables such as light intensity and spectrum, temperature, humidity, etc. contributing to higher quality agricultural products;
- The ability to customize the growing environment for each genetic variety of crop, maximizing the quality and yield;
- The Grow Pods provide an attractive return on invested capital for cash crops;
- The modular format and controlled environment minimize the risk of contamination from plant diseases or pests; and
- The modular format minimizes the risk of materially significant crop loss.
For more information contact:
Grow Pod information and quote Contact:
Kelsey Friesen, Director of Grow Pod Sales
Investor & Media Contact:
Ian Chadsey, VP Corporate Affairs
About Delta 9 Cannabis Inc.
Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQX under the symbol "DLTNF". For more information, please visit www.delta9.ca.
Disclaimer for Forward-Looking Information
Certain statements in this release are forward-looking statements, which reflect the expectations of management regarding the Company's future business plans and other matters. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future. Forward looking statements in this news release include statements relating to: (i) the Company’s plans to market its B2B products in the United States, (ii) the Company’s plans to increase marketing efforts in the United States, and (iii) Malach’s intent and ability to manufacture Grow Pods in the USA. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the statements, including Dry Island’s cannabis production not being as anticipated, as well as all risk factors set forth in the annual information form of Delta 9 dated March 31, 2021 which has been filed on SEDAR. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully in evaluating the forward-looking statements contained in this news release and are cautioned not to place undue reliance on such forward-looking statements, which are qualified in their entirety by these cautionary statements. These forward-looking statements are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.